ABSTRACT: Background: Despite the increasing use of atherectomy, few studies have compared outcomes of endovascular procedures performed in an outpatient office-based laboratory (OBL) to those performed in the traditional hospital setting. As the trend for increased outpatient treatment continues, it is critical to begin to assess the procedural outcomes of atherectomy in the OBL setting. Methods: We analyzed the CONFIRM registry series, a data collection of patients with peripheral arterial disease (PAD) who were treated with orbital atherectomy in both the OBL and hospital settings. Results: We found that 36% of patients in both the hospital and OBL groups were classified as Rutherford class III (P=.96) and the lesions treated were moderately to severely calcified (angiographic evaluation) in 83% and 90% of patients in the hospital and OBL setting, respectively (P=.07). Final residual stenosis after adjunctive therapy was 10%±11% in the hospital group and 11%±17% in the OBL group (P=.32). Dissections, including flow limiting and non-flow limiting, occurred in 11.4% of lesions in the hospital group vs 6.5% in the OBL group (P=.12). Adjusted logistic regressions showed no difference in any individual complication rate or the overall complication rate. Conclusions: Orbital atherectomy treatment of PAD in an OBL was found to be comparable to treatment in a hospital setting. Due to the emergence of more OBLs utilizing orbital atherectomy, a follow-up prospective study is warranted to further investigate the comparative outcomes within a larger patient population. insufficient results in more calcified lesions, leading to a high rate of bail-out stenting. 2 Self-expanding nitinol stents have improved outcomes in PAD, however reported fracture rates have ranged from 3% to 37%, with higher fracture rates in longer and more calcified lesions. [2] [3] [4] Atherectomy has emerged as a treatment option for heavily calcified peripheral lesions to improve luminal diameter with the potential to prepare the lesion for more uniform circumferential expansion with PTA and better stent apposition. [5] [6] [7] [8] With the advent of endovascular office-based laboratories (OBL), many minimally invasive vascular proce- 
METHODS
The OAS is a novel system for the treatment of PAD and has been previously described. [9] [10] [11] This per- Table 1 .
There were no appreciable differences between the two groups in regard to gender, smoking habits, history of diabetes, hypertension, hyperlipidemia, coronary artery disease, or renal disease. Mean Ankle Brachial Index (ABI) was similar: 0.61±0.27 and 0.59±0.27 for hospital and OBL settings, respectively (P=.69).
In both settings, 36% of patients were classified as Rutherford class III (P=.96). However the hospital group had a higher incidence of patients with critical limb ischemia (Rutherford class IV-VI): 44% vs 23% (P=.0003). This is expected since many critical limb ischemia patients are already hospitalized when the vascular specialist is consulted, whereas the treating physician may feel that some elective cases are best treated in an outpatient setting.
Procedural Data. Based on the investigator's visual estimate, 83% and 90% of lesions were moderately to severely calcified in the hospital and OBL settings, respectively (P=.07). Procedural data are presented by group in Table 2 . As shown, in both settings the physician treated a similar number of lesions. The number of lesions treated both above the knee and below the knee was similar in both settings. However, in the hospital Table 3 .
Procedural Complications
As shown in Table 4 , the most common procedural complication was dissection, including flow-limiting and non-flow-limiting, which occurred in 11.4% of lesions in the hospital group vs 6.5% of lesions in the OBL group (P=.12). Of the 7 dissections reported in the OBL group, 6 were treated with a stent and none were classified as flow limiting by the treating physician. In the hospital group, dissections were attributed to PTA in 45.3% of lesions.
None of the complication rates were significantly different by group using an unadjusted logistic regression; however, the overall event rate was significantly greater in the hospital group (22.1% vs 13.0%, P=.03). Adjusted logistic regressions were also conducted, adjusting for significantly different demographic and procedural data (Rutherford class, lesion length, adjunctive therapy, number of devices, total running time, and lesion location). After adjusting for these factors, there was no difference in any individual complication rate or the overall complication rate.
DISCUSSION
To date, published data evaluating acute outcomes of endovascular technologies for treatment of PAD in the OBL setting compared to the traditional hospital setting are almost nonexistent. However, several pub- can be performed in the office-based setting with low complication rates. [13] [14] [15] The OAS provides an effective means to reduce atherosclerotic plaque in peripheral arterial lesions. 
